1-4 of 4
Kyle T. Jones
Close
Sort by
Journal Articles

Phase I Trial of Regulatory T-Cell Donor Lymphocyte Infusion Plus Daily Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Versus-Host Disease

Sarah Nikiforow, MD PhD, Haesook T Kim, PhD, Kyle T Jones, Jeremy Stewart, BA, Heather Garrity, Heather Daley, Shanna Richard, Renee Manduke, Marie Chammas, BSc, Carol Reynolds, PhD, Andrew Burden, Jennifer Whangbo, MD PhD, Bruce Blazar, MD, Philippe Armand, MD PhD, Vincent T Ho, MD, Edwin Alyea, MD, Corey Cutler, MD MPH, FRCPC, Joseph H. Antin, MD, Robert J. Soiffer, MD, Jerome Ritz, MD, John Koreth, MBBS, DPhil
Journal: Blood
Blood (2017) 130 (Supplement 1): 511.
https://doi.org/10.1182/blood.V130.Suppl_1.511.511
Published: 2017
Journal Articles

Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease

Clinical Trials & Observations
John Koreth, Haesook T. Kim, Kyle T. Jones, Paulina B. Lange, Carol G. Reynolds, Marie J. Chammas, Katherine Dusenbury, Jennifer Whangbo, Sarah Nikiforow, Edwin P. Alyea, III, Philippe Armand, Corey S. Cutler, Vincent T. Ho, Yi-Bin Chen, David Avigan, Bruce R. Blazar, Joseph H. Antin, Jerome Ritz, Robert J. Soiffer
Journal: Blood
Blood (2016) 128 (1): 130–137.
https://doi.org/10.1182/blood-2016-02-702852
Published: 2016
Includes: Supplemental data
Journal Articles

Long-Term Homeostatic Effects of Daily Low-Dose IL-2 on CD4+ FoxP3+ Regulatory T Cells in Patients with Active Chronic Graft-Versus-Host Disease

Jennifer Whangbo, MD PhD, John Koreth, MBBS, DPhil, Haesook T. Kim, PhD, Katharine Dusenbury, Ana Cristina Alho, MD, Carol G Reynolds, PhD, Marie J Chammas, Kyle T Jones, Sarah Nikiforow, MD PhD, Corey S Cutler, MD MPH, Vincent T. Ho, MD, Philippe Armand, MD PhD, Edwin P. Alyea, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Jerome Ritz, MD
Journal: Blood
Blood (2015) 126 (23): 3133.
https://doi.org/10.1182/blood.V126.23.3133.3133
Published: 2015
Journal Articles

Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs.-Host Disease: Phase 2 and Long Term Efficacy, Safety and Immune Correlates

John Koreth, MBBS, DPhil, Haesook T. Kim, PhD, Kyle T. Jones, BSc, Carol G Reynolds, PhD, Marie J Chammas, BSc, Katherine Dusenbury, BSc, Jennifer Whangbo, MD PhD, Sarah Nikiforow, MD PhD, Edwin P. Alyea, MD, Philippe Armand, MD PhD, Corey S Cutler, MD MPH, Vincent T Ho, MD, Yi-Bin Chen, MD, David Avigan, MD, Joseph H Antin, MD, Jerome Ritz, MD, Robert J Soiffer, MD
Journal: Blood
Blood (2014) 124 (21): 41.
https://doi.org/10.1182/blood.V124.21.41.41
Published: 2014